Kavalacton (Dutch Wikipedia)

Analysis of information sources in references of the Wikipedia article "Kavalacton" in Dutch language version.

refsWebsite

Global rank Dutch rank

7doi.org

2^nd place

8^th place

6nih.gov

4^th place

12^th place

2web.archive.org

1^st place

1aspetjournals.org

6,663^rd place

low place

1unodc.org

2,494^th place

4,528^th place

1sigmaaldrich.com

924^th place

906^th place

1worldcat.org

5^th place

28^th place

aspetjournals.org

dmd.aspetjournals.org

James M. Mathews, Amy S. Etheridge, Sherry R. Black (2002). Inhibition of Human Cytochrome P450 Activities by Kava Extract and Kavalactones. Drug Metabolism and Disposition 30 (11): 1153–1157. PMID 12386118. DOI: 10.1124/dmd.30.11.1153. Gearchiveerd van origineel op 29 januari 2023.

doi.org

James M. Mathews, Amy S. Etheridge, Sherry R. Black (2002). Inhibition of Human Cytochrome P450 Activities by Kava Extract and Kavalactones. Drug Metabolism and Disposition 30 (11): 1153–1157. PMID 12386118. DOI: 10.1124/dmd.30.11.1153. Gearchiveerd van origineel op 29 januari 2023.
(en) Sarris, Jerome, LaPorte, Emma, Schweitzer, Isaac (1 januari 2011). Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology. Australian & New Zealand Journal of Psychiatry 45 (1): 27–35. PMID 21073405. DOI: 10.3109/00048674.2010.522554.
Teschke, R, Lebot, V (2011). Proposal for a kava quality standardization code. Food and Chemical Toxicology 49 (10): 2503–16. PMID 21756963. DOI: 10.1016/j.fct.2011.06.075.
Wang, J, Qu, W, Bittenbender, H. C., Li, Q. X. (2013). Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents. Journal of Food Science and Technology 52 (2): 1164–1169. PMID 25694734. PMC 4325077. DOI: 10.1007/s13197-013-1047-2.
Teschke, R, Qiu, S. X., Xuan, T. D., Lebot, V (2011). Kava and kava hepatotoxicity: Requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. Phytotherapy Research 25 (9): 1263–74. PMID 21442674. DOI: 10.1002/ptr.3464.
Naumov, P., Dragull, K., Yoshioka, M., Tang, C.-S., Ng, S. W. (2008). Structural Characterization of Genuine (-)-Pipermethystine, (-)-Epoxypipermethystine, (+)-Dihydromethysticin and Yangonin from the Kava Plant (Piper methysticum). Natural Product Communications 3 (8): 1333–1336. DOI: 10.1177/1934578X0800300819. Gearchiveerd van origineel op 2 maart 2019. Geraadpleegd op 2 april 2022.
Pluskal, Tomáš, Torrens-Spence, Michael P., Fallon, Timothy R., De Abreu, Andrea, Shi, Cindy H. (22 juli 2019). The biosynthetic origin of psychoactive kavalactones in kava. Nature Plants 5 (8): 867–878 (Springer Science and Business Media LLC). ISSN: 2055-0278. PMID 31332312. DOI: 10.1038/s41477-019-0474-0.

nih.gov

ncbi.nlm.nih.gov

James M. Mathews, Amy S. Etheridge, Sherry R. Black (2002). Inhibition of Human Cytochrome P450 Activities by Kava Extract and Kavalactones. Drug Metabolism and Disposition 30 (11): 1153–1157. PMID 12386118. DOI: 10.1124/dmd.30.11.1153. Gearchiveerd van origineel op 29 januari 2023.
(en) Sarris, Jerome, LaPorte, Emma, Schweitzer, Isaac (1 januari 2011). Kava: A Comprehensive Review of Efficacy, Safety, and Psychopharmacology. Australian & New Zealand Journal of Psychiatry 45 (1): 27–35. PMID 21073405. DOI: 10.3109/00048674.2010.522554.
Teschke, R, Lebot, V (2011). Proposal for a kava quality standardization code. Food and Chemical Toxicology 49 (10): 2503–16. PMID 21756963. DOI: 10.1016/j.fct.2011.06.075.
Wang, J, Qu, W, Bittenbender, H. C., Li, Q. X. (2013). Kavalactone content and chemotype of kava beverages prepared from roots and rhizomes of Isa and Mahakea varieties and extraction efficiency of kavalactones using different solvents. Journal of Food Science and Technology 52 (2): 1164–1169. PMID 25694734. PMC 4325077. DOI: 10.1007/s13197-013-1047-2.
Teschke, R, Qiu, S. X., Xuan, T. D., Lebot, V (2011). Kava and kava hepatotoxicity: Requirements for novel experimental, ethnobotanical and clinical studies based on a review of the evidence. Phytotherapy Research 25 (9): 1263–74. PMID 21442674. DOI: 10.1002/ptr.3464.
Pluskal, Tomáš, Torrens-Spence, Michael P., Fallon, Timothy R., De Abreu, Andrea, Shi, Cindy H. (22 juli 2019). The biosynthetic origin of psychoactive kavalactones in kava. Nature Plants 5 (8): 867–878 (Springer Science and Business Media LLC). ISSN: 2055-0278. PMID 31332312. DOI: 10.1038/s41477-019-0474-0.

sigmaaldrich.com

Kava (Piper methysticum): Pharmacodynamics/Kinetics. Sigma-Aldrich Co. LLC (2010).

unodc.org

Shulgin, A. (1973). The narcotic pepper - the chemistry and pharmacology of Piper methysticum and related species. Bulletin on Narcotics (2): 59–74.

web.archive.org

James M. Mathews, Amy S. Etheridge, Sherry R. Black (2002). Inhibition of Human Cytochrome P450 Activities by Kava Extract and Kavalactones. Drug Metabolism and Disposition 30 (11): 1153–1157. PMID 12386118. DOI: 10.1124/dmd.30.11.1153. Gearchiveerd van origineel op 29 januari 2023.
Naumov, P., Dragull, K., Yoshioka, M., Tang, C.-S., Ng, S. W. (2008). Structural Characterization of Genuine (-)-Pipermethystine, (-)-Epoxypipermethystine, (+)-Dihydromethysticin and Yangonin from the Kava Plant (Piper methysticum). Natural Product Communications 3 (8): 1333–1336. DOI: 10.1177/1934578X0800300819. Gearchiveerd van origineel op 2 maart 2019. Geraadpleegd op 2 april 2022.

worldcat.org

Pluskal, Tomáš, Torrens-Spence, Michael P., Fallon, Timothy R., De Abreu, Andrea, Shi, Cindy H. (22 juli 2019). The biosynthetic origin of psychoactive kavalactones in kava. Nature Plants 5 (8): 867–878 (Springer Science and Business Media LLC). ISSN: 2055-0278. PMID 31332312. DOI: 10.1038/s41477-019-0474-0.